SCHEMBL8873797

SCHEMBL8873797

C=CCOC(=O)C1(C)CCC(=O)C2CN(Cc3ccccc3)CC21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.35
MGLL Q99685 1/20 0.35
S1PR5 Q9H228 2/20 0.35
S1PR1 P21453 1/20 0.35
CYP2D6 P10635 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GAA P10253 1/20 0.34
CCR5 P51681 2/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8875025 0.76 GAA (0.46) S1PR5S1PR1GAARORCFUCA1
SCHEMBL8874365 0.75 GAA (0.44) CYP3A4CYP2C19ALDH1A1MEN1KMT2A
SCHEMBL8874334 0.73 TACR1 (0.40) S1PR5S1PR1CYP2D6CYP3A4CYP2C19
SCHEMBL9003052 0.70 TACR1 (0.48) CYP3A4CYP2C19MEN1KMT2AMAPT
SCHEMBL9003055 0.70 TACR1 (0.48) CYP3A4CYP2C19MEN1KMT2AMAPT
SCHEMBL9268452 0.70 TACR1 (0.48) CYP3A4CYP2C19MEN1KMT2AMAPT
SCHEMBL11872365 0.69 TSHR (0.45) MGLLCYP2D6CYP3A4CYP2C9CYP2C19
SCHEMBL8875253 0.69 CHRM4 (0.44) CYP3A4CYP2C19ALDH1A1MEN1KMT2A
SCHEMBL11879597 0.69 LMNA (0.47) CYP2D6CYP3A4CYP2C9CYP2C19KDM4E
SCHEMBL28934869 0.68 CYP3A4 (0.53) S1PR5S1PR1CYP2D6CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5624950-A USEFUL IN TREATMENT OF ANALGESIA, INFLAMMATION, ASTHMA, ALLERGIES, CENTRAL NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS, IMMUNE SYSTEM DISORDERS, ANTISPASMODIC AGENTS, ANTIEMETIC AGENTS RHONE-POULENC RORER S.A. (FR) 1997-04-29 US disclosed